s6y
Company name or ticker
Search
VERTEX PHARMACEUTICALS INC / MA
3
Brennan Daniel J.: Initial statement of beneficial ownership of securities
Filed
Thursday, October 22, 2026
Period
Oct 20, 2026
Accession number
0000875320-26-000281
Documents
FORM 3
3
EX-24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header